Pillstats
Tablet

Furosemide

Furosemide

1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US3 NDCs
1 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCC03CA01
RxCUI (US)4603
US makers1 labelers
Packages9
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.011$0.021$0.032$0.043Dec 2025Apr 2026Jul 2026
$0.036
Latest avg · Jul 22, 2026
-3%
Since Dec 17, 2025
1
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

4.0K8.0K12K16K2025 Q42026 Q1
14K
Rx · 2026 Q1
580K
Units dispensed
2
Quarters · since 2025 Q4

Who makes it1 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Aurobindo Pharma Limitedunknown9SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.